We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLBS
7151
DELISTED
iPath US Treasury Long Bond Bear ETN
DLBS
$13K ﹤0.01%
1,181
-988
-46% -$9.25K
DDMX
7152
DELISTED
DD3 Acquisition Corp. S A de CV
DDMX
$13K ﹤0.01%
+1,318
New +$13.4K
MNTX
7153
DELISTED
Manitex International, Inc.
MNTX
$13K ﹤0.01%
2,263
+1,704
+305% +$9.72K
BZM
7154
DELISTED
BlackRock Maryland Municipal Bond Trust
BZM
$13K ﹤0.01%
808
-2,012
-71% -$29.3K
PGM
7155
DELISTED
iPath Series B Bloomberg Platinum Subindex Total ReturnSM ETN
PGM
$13K ﹤0.01%
284
AVAL icon
7156
Grupo Aval
AVAL
$6.07B
$12K ﹤0.01%
1,354
+814
+151% +$6.56K
AVNW icon
7157
Aviat Networks
AVNW
$272M
$12K ﹤0.01%
1,684
-864
-34% -$6.08K
BNGO icon
7158
Bionano Genomics
BNGO
$12.6M
$12K ﹤0.01%
+17
New +$9.94K
COE
7159
51Talk Online Education Group
COE
$115M
$12K ﹤0.01%
312
-128
-29% -$3.66K
CSBR icon
7160
Champions Oncology
CSBR
$72.1M
$12K ﹤0.01%
+1,398
New +$8.63K
DAIO icon
7161
Data I/O
DAIO
$30.7M
$12K ﹤0.01%
2,763
-443
-14% -$1.78K
FDEM icon
7162
Fidelity Emerging Markets Multifactor ETF
FDEM
$578M
$12K ﹤0.01%
477
+164
+52% +$4.06K
FLRT icon
7163
Pacer Aristotle Pacific Floating Rate High Income ETF
FLRT
$661M
$12K ﹤0.01%
235
-6
-2% -$293
FSI icon
7164
Flexible Solutions
FSI
$64.2M
$12K ﹤0.01%
+4,789
New +$12.3K
KOSS icon
7165
Koss Corp
KOSS
$35.3M
$12K ﹤0.01%
7,479
+3,591
+92% +$6.12K
NOA
7166
North American Construction
NOA
$393M
$12K ﹤0.01%
1,000
OPOF
7167
DELISTED
Old Point Financial
OPOF
$12K ﹤0.01%
448
+168
+60% +$4.5K
PAVS icon
7168
Paranovus Entertainment Technology
PAVS
$5.94M
0
PW
7169
Power REIT
PW
$2.9M
$12K ﹤0.01%
132
-80
-38% -$7.08K
QUAD icon
7170
Quad
QUAD
$515M
$12K ﹤0.01%
2,557
-67,472
-96% -$422K
RKDA icon
7171
Arcadia Biosciences
RKDA
$1.56M
$12K ﹤0.01%
56
-41
-42% -$8.22K
RMCF icon
7172
Rocky Mountain Chocolate Factory
RMCF
$7.93M
$12K ﹤0.01%
1,297
-127
-9% -$1.14K
SEED icon
7173
Origin Agritech
SEED
$12.6M
$12K ﹤0.01%
2,238
-949
-30% -$5.15K
SNOA icon
7174
Sonoma Pharmaceuticals
SNOA
$5.98M
$12K ﹤0.01%
135
+17
+14% +$1.7K
SNT
7175
Senstar Technologies
SNT
$43.4M
$12K ﹤0.01%
3,270
-1,913
-37% -$7.65K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.